Neuralink, the neurotechnology company Elona Muska announced the closing of the financing round in which it raised $ 650 million. Now the clinical trials of the device equipped with the integrated circuit processing neural signals, which can be sent to computers or telephones. Cerebral implants are clinically tested on patients in three countries.
Five patients use the Neuralink implant
According to the company’s information, Reuters appoints, Five patients with severe paralysis use neuralink to control digital and physical devices using thoughts.
Thanks to increased financing, the number of people who will be able to use this revolutionary solution will be greater.
“Thanks to this financing, we can provide our technology with more people “Restoring unmet medical needs to people and shifting the limits of the abilities of the brain interfaces,” Reuters quotes the neuralink message.
Breakthrough technology
The American Food and Drug Agency has admitted “breakthrough” label for two neuralinka projects. Last month, Neuralink received this title for its device for restore speech. Last year, Muska received the same label for the device for restoring sight.
Faster commercialization of the project
The substantial amount collected in the last financing round is aimed at accelerating the commercialization of the project. As reported on the program’s website, this will enable patients and healthcare providers faster access to medical devices through Acceleration of their development, evaluation and review.
$ 650 million for neuralinks
Neuralink closed the funding round with the participation of key investors, including Ark Invest, DFJ Growth, Founders Fund, G42, Human Capital, LightSpeed, Qia, Sequoia Capital, Thrive Capital, Valor Equity Partners and Vy Capital, the company said.
Source: Reuters
